Glenmede Trust CO Na Bio Rad Laboratories, Inc. Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 1,050 shares of BIO stock, worth $367,741. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,050Holding current value
$367,741% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding BIO
# of Institutions
456Shares Held
18.2MCall Options Held
17.6KPut Options Held
13.3K-
Vanguard Group Inc Valley Forge, PA1.91MShares$668 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$543 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$457 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$381 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$250 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.63B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...